{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:29Z","timestamp":1786119689282,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4,15]]},"DOI":"10.1097\/tp.0b013e31820f0877","type":"journal-article","created":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T04:22:11Z","timestamp":1298002931000},"page":"757-764","source":"Crossref","is-referenced-by-count":73,"title":["Incidence and Risk Factors of Glucose Metabolism Disorders in Kidney Transplant Recipients: Role of Systematic Screening by Oral Glucose Tolerance Test"],"prefix":"10.1097","volume":"91","author":[{"given":"Sophie","family":"Caillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Eprinchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise","family":"Heibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"10 suppl","key":"R1-11-20210129","first-page":"SS3","article-title":"New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003.","volume":"75","author":"Davidson","year":"2003","journal-title":"Transplantation"},{"key":"R2-11-20210129","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1600-6143.2003.00010.x","article-title":"Diabetes mellitus after kidney transplantation in the United States.","volume":"3","author":"Kasiske","year":"2003","journal-title":"Am J Transplant"},{"key":"R3-11-20210129","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/ndt\/18.1.164","article-title":"Post-transplant hyperglycaemia: A study of risk factors.","volume":"18","author":"Mathew","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R4-11-20210129","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","article-title":"Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus.","volume":"7","author":"Vincenti","year":"2007","journal-title":"Am J Transplant"},{"key":"R5-11-20210129","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1681\/ASN.2007111202","article-title":"Sirolimus is associated with new-onset diabetes in kidney transplant recipients.","volume":"19","author":"Johnston","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R6-11-20210129","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1111\/j.1600-6143.2005.01040.x","article-title":"Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: Meta-analysis of clinical studies.","volume":"5","author":"Fabrizi","year":"2005","journal-title":"Am J Transplant"},{"key":"R7-11-20210129","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2215\/CJN.09481209","article-title":"Relationship between inpatient hyperglycemia and insulin treatment after kidney transplantation and future new onset diabetes mellitus.","volume":"5","author":"Chakkera","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R8-11-20210129","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2215\/CJN.05360709","article-title":"New-onset diabetes mellitus after kidney transplantation in Denmark.","volume":"5","author":"Hornum","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"suppl 2","key":"R9-11-20210129","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.2215\/CJN.02650707","article-title":"New-onset diabetes mellitus in the kidney recipient: Diagnosis and management strategies.","volume":"3","author":"Bloom","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R10-11-20210129","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2337\/dc07-1005","article-title":"A variant of the transcription factor 7-like 2 (TCF7L2) gene and the risk of posttransplantation diabetes mellitus in renal allograft recipients.","volume":"31","author":"Kang","year":"2008","journal-title":"Diabetes Care"},{"key":"R11-11-20210129","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1681\/ASN.2008121314","article-title":"TCF7L2 polymorphism associates with new-onset diabetes after transplantation.","volume":"20","author":"Ghisdal","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R12-11-20210129","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/sj.ki.5000116","article-title":"The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events.","volume":"69","author":"Hjelmesaeth","year":"2006","journal-title":"Kidney Int"},{"key":"R13-11-20210129","doi-asserted-by":"crossref","first-page":"814","DOI":"10.2215\/CJN.04681107","article-title":"Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival.","volume":"3","author":"Cole","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R14-11-20210129","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1523-1755.2002.kid582.x","article-title":"Patient survival after renal transplantation: IV. Impact of post-transplant diabetes.","volume":"62","author":"Cosio","year":"2002","journal-title":"Kidney Int"},{"key":"R15-11-20210129","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1432-2277.2008.00640.x","article-title":"Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation.","volume":"21","author":"Roland","year":"2008","journal-title":"Transpl Int"},{"key":"R16-11-20210129","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1046\/j.1523-1755.2001.059002732.x","article-title":"Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years.","volume":"59","author":"Cosio","year":"2001","journal-title":"Kidney Int"},{"key":"R17-11-20210129","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s001250051211","article-title":"Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. The DECODE-study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic Criteria in Europe.","volume":"42","year":"1999","journal-title":"Diabetologia"},{"key":"R18-11-20210129","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1097\/01.tp.0000250924.99855.42","article-title":"The use of oral glucose tolerance tests to risk stratify new onset diabetes after transplantation: an underdiagnosed phenomenon.","volume":"82","author":"Sharif","year":"2006","journal-title":"Transplantation"},{"key":"R19-11-20210129","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2337\/diacare.20.4.537","article-title":"Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.","volume":"20","author":"Pan","year":"1997","journal-title":"Diabetes Care"},{"key":"R20-11-20210129","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.tp.0000248759.37146.3d","article-title":"Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation.","volume":"83","author":"Hamer","year":"2007","journal-title":"Transplantation"},{"key":"R21-11-20210129","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/ndt\/14.5.1244","article-title":"Polycystic kidney disease as a risk factor for post-transplant diabetes mellitus.","volume":"14","author":"Ducloux","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"R22-11-20210129","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1523-1755.2005.67132.x","article-title":"Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation.","volume":"67","author":"de Mattos","year":"2005","journal-title":"Kidney Int"},{"key":"R23-11-20210129","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1053\/j.ackd.2010.01.003","article-title":"Extrarenal manifestations of autosomal dominant polycystic kidney disease.","volume":"17","author":"Pirson","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"R24-11-20210129","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ki.1997.360","article-title":"Insulin resistance in adult polycystic kidney disease.","volume":"52","author":"Vareesangthip","year":"1997","journal-title":"Kidney Int"},{"key":"R25-11-20210129","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1053\/j.ajkd.2007.06.016","article-title":"Massively enlarged polycystic kidneys in monozygotic twins with TCF2\/HNF-1beta (hepatocyte nuclear factor-1beta) heterozygous whole-gene deletion.","volume":"50","author":"Faguer","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R26-11-20210129","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1600-6143.2003.00372.x","article-title":"New onset diabetes mellitus in patients receiving calcineurin inhibitors: A systematic review and meta-analysis.","volume":"4","author":"Heisel","year":"2004","journal-title":"Am J Transplant"},{"key":"R27-11-20210129","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1136\/bmj.318.7191.1104","article-title":"Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: Meta-analysis of randomised trials.","volume":"318","author":"Knoll","year":"1999","journal-title":"BMJ"},{"key":"R28-11-20210129","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1600-6143.2004.00591.x","article-title":"Development of diabetes mellitus following kidney transplantation: A Canadian experience.","volume":"4","author":"Gourishankar","year":"2004","journal-title":"Am J Transplant"},{"key":"R29-11-20210129","doi-asserted-by":"crossref","first-page":"616","DOI":"10.2215\/CJN.07501009","article-title":"Undiagnosed diabetes in kidney transplant candidates: A case-finding strategy.","volume":"5","author":"Bergrem","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R30-11-20210129","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/TP.0b013e3181af1f53","article-title":"Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation.","volume":"88","author":"Valderhaug","year":"2009","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0b013e31820f0877","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:56:20Z","timestamp":1786042580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-201104150-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,15]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e31820f0877","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4,15]]}}}